1 Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
2 Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
Cephalalgia. 2018 Apr;38(5):833-845. doi: 10.1177/0333102417712719. Epub 2017 May 29.
Background Recent genome-wide association studies have identified transient receptor potential M8 ( TRPM8) as a migraine susceptibility gene. TRPM8 is a nonselective cation channel that mediates cool perception. However, its precise role in migraine pathophysiology is elusive. Transient receptor potential V1 (TRPV1) is a nonselective cation channel activated by noxious heat. Both TRPM8 and TRPV1 are expressed in trigeminal ganglion (TG) neurons. Methods We investigated the functional roles of TRPM8 and TRPV1 in a meningeal inflammation-based migraine model by measuring the effects of facial TRPM8 activation on thermal allodynia and assessing receptor coexpression changes in TG neurons. We performed retrograde tracer labeling to identify TG neurons innervating the face and dura. Results We found that pharmacological TRPM8 activation reversed the meningeal inflammation-induced lowering of the facial heat pain threshold, an effect abolished by genetic ablation of TRPM8. No significant changes in the heat pain threshold were seen in sham-operated animals. Meningeal inflammation caused dynamic alterations in TRPM8/TRPV1 coexpression patterns in TG neurons, and colocalization was most pronounced when the ameliorating effect of TRPM8 activation on thermal allodynia was maximal. Our tracer assay disclosed the presence of dura-innervating TG neurons sending collaterals to the face. Approximately half of them were TRPV1-positive. We also demonstrated functional inhibition of TRPV1 by TRPM8 in a cell-based assay using c-Jun N-terminal kinase phosphorylation as a surrogate marker. Conclusions Our findings provide a plausible mechanism to explain how facial TRPM8 activation can relieve migraine by suppressing TRPV1 activity. Facial TRPM8 appears to be a promising therapeutic target for migraine.
最近的全基因组关联研究已经确定瞬时受体电位 M8(TRPM8)是偏头痛易感性基因。TRPM8 是一种非选择性阳离子通道,介导冷觉。然而,其在偏头痛病理生理学中的确切作用尚不清楚。瞬时受体电位 V1(TRPV1)是一种非选择性阳离子通道,可被有害热激活。TRPM8 和 TRPV1 均在三叉神经节(TG)神经元中表达。
我们通过测量面部 TRPM8 激活对热痛觉过敏的影响,并评估 TG 神经元中受体共表达变化,研究了 TRPM8 和 TRPV1 在基于脑膜炎症的偏头痛模型中的功能作用。我们进行逆行示踪标记以鉴定支配面部和硬脑膜的 TG 神经元。
我们发现,药理学 TRPM8 激活逆转了脑膜炎症引起的面部热痛觉阈值降低,而 TRPM8 基因缺失则消除了这种作用。假手术动物的热痛觉阈值没有明显变化。脑膜炎症导致 TG 神经元中 TRPM8/TRPV1 共表达模式发生动态变化,当 TRPM8 激活对热痛觉过敏的改善作用最大时,共表达最为明显。我们的示踪剂测定显示,存在支配硬脑膜的 TG 神经元向面部发出侧支。其中约一半是 TRPV1 阳性的。我们还在使用 c-Jun N 末端激酶磷酸化作为替代标记的基于细胞的测定中证明了 TRPV1 受 TRPM8 的功能抑制。
我们的发现提供了一种合理的机制来解释面部 TRPM8 激活如何通过抑制 TRPV1 活性来缓解偏头痛。面部 TRPM8 似乎是治疗偏头痛的有前途的靶点。